Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Unilateral and Bilateral taVNS in Fibromyalgia

NCT: NCT07577102 · COMPLETED

NCT IDNCT07577102
StatusCOMPLETED
Start Date2022-01-01
Completion2023-06-20

Brief Summary

This randomized controlled trial aimed to compare the effects of unilateral (left-sided) and bilateral transcutaneous auricular vagus nerve stimulation (taVNS) combined with a home exercise program on clinical outcomes, autonomic nervous system function, and exercise performance in individuals with fibromyalgia syndrome (FMS). Participants diagnosed with fibromyalgia were randomly assigned to one of three groups: unilateral taVNS, bilateral taVNS, or a home exercise program. The intervention period lasted two weeks and included ten treatment sessions. Clinical outcomes were assessed using validated scales including the Fibromyalgia Impact Questionnaire (FIQ), Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), and Pittsburgh Sleep Quality Index (PSQI). Autonomic function was evaluated using heart rate variability (HRV) parameters, and exercise performance was assessed based on repetition capacity. The study aimed to determine whether bilateral stimulation provides additional benefits compared to unilateral stimulation and exercise alone. The findings may contribute to understanding the role of neuromodulation strategies in improving autonomic regulation, symptom severity, and functional performance in individuals with fibromyalgia.

Frequently Asked Questions

What is Unilateral and Bilateral taVNS in Fibromyalgia?

Unilateral and Bilateral taVNS in Fibromyalgia is a clinical trial registered under NCT07577102. Current status: COMPLETED.

What is the status of NCT07577102?

The current status of NCT07577102 (Unilateral and Bilateral taVNS in Fibromyalgia) is: COMPLETED.

When did Unilateral and Bilateral taVNS in Fibromyalgia start?

Unilateral and Bilateral taVNS in Fibromyalgia started on 2022-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.